PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Akzo Nobel_February_2020_757_51757 - AkzoNobel | Presentation Nation

HomepageAkzoNobelAkzo Nobel_February_2020_757_51757

Akzo Nobel_February_2020_757_51757

AkzoNobel

Browse presentations, reports, and documents from AkzoNobel.

Tags

2020

Filter options

All (49)●
annual_report (1)○
brochure (4)○
case-study (2)○
earnings (2)○
infographic (3)○
investor_presentation (1)○
presentation (25)○
report (11)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Akzo Nobel_February_2020_757_51757 by AkzoNobel.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from AkzoNobel

AKZOINDIA_04082023154133_AkzoInvestorPresentation4Aug23

presentation

AkzoNobel 2022 Investor Update Grow Deliver

investor_presentation

investor_presentation

Similar presentations from other companies

Capstone Copper_August_2024_867_102867

presentation

Capstone Copper Corporation

Ingram-Micro-Cyber-Security-Portfolio

presentation

Ingram Micro

76 Pages

AkzoNobel 2025 Annual Report

annual_report

237 Pages

AkzoNobel-Aerospace-QPL

brochure

Akzo Nobel_April_2018_417_25417

presentation

Akzo Nobel_April_2020_61_54061

presentation

Portland General Electric_October_2017_883_15883

presentation

General Electric

UGI Corporation__2023__206_93206

presentation

UGI Corporation

Check Point Software Technologies_February_2022_794_78794

presentation

Check Point Software Technologies

BMY-2022-Q2-Results-Investor-Presentation-Appendix

presentation

Bristol Myers Squibb